Belaidi, Abdel Ali http://orcid.org/0000-0003-0792-8728
Masaldan, Shashank http://orcid.org/0000-0003-4960-4983
Southon, Adam
Kalinowski, Pawel
Acevedo, Karla
Appukuttan, Ambili T.
Portbury, Stuart
Lei, Peng http://orcid.org/0000-0001-5652-1962
Agarwal, Puja http://orcid.org/0000-0002-0274-6653
Leurgans, Sue E. http://orcid.org/0000-0003-2536-1665
Schneider, Julie
Conrad, Marcus http://orcid.org/0000-0003-1140-5612
Bush, Ashley I. http://orcid.org/0000-0001-8259-9069
Ayton, Scott http://orcid.org/0000-0002-3479-2427
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council
Alzheimer's Association (AARFD-16-442821)
Article History
Received: 8 September 2021
Revised: 27 March 2022
Accepted: 6 April 2022
First Online: 28 April 2022
Competing interests
: AIB is a shareholder in Alterity Biotechnology Ltd, Cogstate Ltd, and Mesoblast Ltd. He is a paid consultant for, and has a profit share interest in, Collaborative Medicinal Development Pty Ltd.